Global Point of Care (POC) Infectious Disease Diagnostic Testing Market Report 2018: Focus on Influenza, STD, HIV, Hepatitis, Malaria, C. difficile, E. coli, H. pylori & Home Test/OTC

Dublin, April 17, 2018 -- The "Point of Care (POC) Infectious Disease Diagnostic Testing Market" report has been added to ResearchAndMarkets.com's offering.

The goal of POC infectious disease testing is to detect pathogens in humans and determine a course of antimicrobial treatment that is the most appropriate for the patient. The threat of infectious diseases is generally associated with developing countries, but infectious diseases are also a major cause of morbidity and mortality in developed countries in Europe and in the U.S.

Various factors such emerging infectious diseases, mass migration, global travelers, misuse of antibiotics and co-infection, lead to a need for continuous global effort and novel avenues of research to fight against these expending threats.

Infectious disease testing will always be a key driver for diagnostic testing because new pathogen strains develop each year, such as in seasonal influenza and H1N1, Lyme disease, West Nile. Additionally, hospital acquired infections, like Methicillin-resistant Staphylococcus aureus (MRSA), necessitate increased testing.

This report provides market sizing and forecasts for the following disease areas:

• Influenza
• STD
• HIV
• Hepatitis
• Malaria
• C. difficile
• E. coli
• H. pylori
• Home Test/OTC
• Others

Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players.

Key Topics Covered:

1: Executive Summary

• Introduction
• Size and Growth of the Market
• Regional Analysis
• Competitive Analysis
• Scope And Methodology
• Trends Affecting The Market
• Competitive Outlook

2: Introduction and Overview

• Overview
• Osteoporosis
• Pregnancy and Fertility
• Point-Of-Care Diagnostics Testing
• Industry Regulations
• Test Types
• Blood
• Urine
• Saliva
• Hair
• Optical Technologies
• Breath
• Products in Infectious Disease POC Testing

3: POC Infectious Disease Testing Market Analysis

Companies Mentioned

• Abbott/Alere
• Atlas Genetics Ltd.
• Atlas Link Biotech Co., Ltd
• Bhat Bio-Tech India Private Ltd. (BBI)
• Biolytical Laboratories
• Biomerica, Inc.
• Boson Biotech Co. Ltd
• Calypte Biomedical Corporation
• Cepheid, Inc (Danaher)
• Chembio Diagnostic Systems, Inc.
• EKF Diagnostics Holdings Plc
• J. Mitra & Co Pvt. Ltd
• Medmira, Inc
• Meridian Bioscience, Inc
• Opko Health, Inc
• Orasure Technologies, Inc.
• Quidel Corporation
• Response Biomedical Corp
• Reszon Diagnostics International Sdn. Bhd.
• Rheonix, Inc
• Savyon Diagnostics
• Sekisui Diagnostics
• Trinity Biotech Plc
• Veredus Laboratories Pte Ltd
• Vircell
• Wama Diagnostica

For more information about this report visit https://www.researchandmarkets.com/research/4jx799/global_point_of?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Point-of-Care Diagnostics, Infectious Disease Testing